The distinction can be challenging, but is crucial, as high‐grade osteosarcoma requires different treatment.20 Molecular analysis of IDH can be helpful, as the presence of this mutation strongly favours chondrosarcoma over chondroblastic osteosarcoma.21 The gene discussed is IDH2; the disease is chondroblastic osteosarcoma.